Protein Kinase Inhibitors: all 15,278 studies that test it

Page 69 of 153. Open to participants first (2,556), then studies with results posted, then the rest; newest registration first within each.

• Pazopanib Plus Lapatinib Compared To Lapatinib Alone In Subjects With Advanced Or Metastatic Breast CancerCompletedNCT00347919Phase 2Results posted
• An Ascending Dose Study of KW-2449 in Acute Leukemias, Myelodysplastic Syndromes, and Chronic Myelogenous LeukemiaTerminatedNCT00346632Phase 1Results posted
• Belatacept to Prevent Organ Rejection in Kidney Transplant PatientsTerminatedNCT00346151Phase 2Results posted
• First-line Treatment for Adenocarcinoma Patients With Epidermal Growth Factor Receptor (EGFR) MutationCompletedNCT00344773Phase 2Results posted
• Study of Dasatinib (BMS-354825) in Patients With Solid TumorsCompletedNCT00339144Phase 1Results posted
• Safety And Effectiveness Of Daily Dosing With 37.5 mg Sunitinib Malate In Patients With Advanced Kidney CancerCompletedNCT00338884Phase 2Results posted
• Letrozole and Imatinib Mesylate in Treating Postmenopausal Participants With Estrogen or Progesterone Positive Metastatic Breast CancerCompletedNCT00338728Phase 2Results posted
• A Phase II Study of Gemcitabine and Erlotinib As Adjuvant Therapy In Patients With Resected Pancreatic CancerTerminatedNCT00336700Phase 2Results posted
• Sorafenib Combined With Erlotinib, Tipifarnib, or Temsirolimus in Treating Patients With Recurrent Glioblastoma Multiforme or GliosarcomaCompletedNCT00335764Phase 1/2Results posted
• Safety and Efficacy of GW786034 (Pazopanib) In Metastatic Renal Cell CarcinomaCompletedNCT00334282Phase 3Results posted
• Safety and Efficacy of Imatinib Versus Interferon-α Plus Cytarabine in Patients With Newly Diagnosed Philadelphia Chromosome Positive Chronic Myelogenous LeukemiaCompletedNCT00333840Phase 3Results posted
• Comparison of CNI-based Regimen Versus CNI-free Regimen in Kidney Transplant Recipients.TerminatedNCT00332839Phase 4Results posted
• PRELUDE:Study to Investigate the Prevention of Relapse in Lymphoma Using Daily EnzastaurinCompletedNCT00332202Phase 3Results posted
• Docetaxel and Flavopiridol in Treating Patients With Refractory Metastatic Pancreatic CancerCompletedNCT00331682Phase 2Results posted
• Everolimus and Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Kidney CancerCompletedNCT00331409Phase 2Results posted
• Evaluation of Sunitinib Malate in Patients With Von Hippel-Lindau Syndrome (VHL) Who Have VHL Lesions to FollowTerminatedNCT00330564Phase 2Results posted
• Sorafenib in Treating Patients With Soft Tissue Sarcomas (Extremity Sarcoma Closed to Entry as of 5/30/07)CompletedNCT00330421Phase 2Results posted
• Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent GlioblastomaCompletedNCT00329719Phase 1/2Results posted
• Sorafenib, Carboplatin, and Paclitaxel in Treating Patients With Stage IV Melanoma of the EyeCompletedNCT00329641Phase 2Results posted
• De Novo Sirolimus-based Immunosuppression After Liver Transplantation for Hepatocellular CarcinomaCompletedNCT00328770Phase 2/3Results posted
• ZD1839 With Hypofractionated Radiation Therapy With an Immobilization Device for Advanced Non-Small Cell Lung CancerCompletedNCT00328562Phase 1Results posted
• Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By SurgeryCompletedNCT00326898Phase 3Results posted
• AZD2171 in Treating Patients With Neurofibromatosis Type 1 and Plexiform Neurofibroma and/or Neurofibroma Near the SpineTerminatedNCT00326872Phase 2Results posted
• BAY 43-9006 Plus Cetuximab to Treat Colorectal CancerCompletedNCT00326495Phase 2Results posted
• Bevacizumab (Avastin) and RAD001(Everolimus)in the Treatment of Advanced Clear Cell Renal CarcinomaCompletedNCT00323739Phase 2Results posted
• Gemcitabine and Imatinib Mesylate in Treating Patients With Recurrent or Metastatic Non-Small Cell Lung CancerTerminatedNCT00323362Phase 2Results posted
• Gemcitabine +/- Imatinib Mesylate, Patients w/Previously Treated Metastatic Breast CancerTerminatedNCT00323063Phase 2Results posted
• First Line IRESSA™ Versus Carboplatin/Paclitaxel in AsiaCompletedNCT00322452Phase 3Results posted
• Comparison of Sirolimus and Azathioprine in Lung TransplantationCompletedNCT00321906Phase 4Results posted
• GW572016 In Patients With ErbB2 Over - Expressing Advanced Or Metastatic Breast CancerCompletedNCT00320411Phase 2Results posted
• Lapatinib In Combination With Trastuzumab Versus Lapatinib Monotherapy In Subjects With HER2-positive Metastatic Breast CancerCompletedNCT00320385Phase 3Results posted
• Study of Dasatinib in Patients With Chronic Phase Chronic Myeloid Leukemia and a Suboptimal Response to ImatinibTerminatedNCT00320190Phase 2Results posted
• Study Evaluating SKI-606 (Bosutinib) In Subjects With Breast CancerCompletedNCT00319254Phase 2Results posted
• Topotecan and Gefitinib (Iressa) for Ovarian, Peritoneal, or Fallopian Tube CancerCompletedNCT00317772Phase 1/2Results posted
• Trastuzumab and RAD001 in Patients With Human Epidermal Growth Receptor 2 (HER-2) Overexpressing Breast CancerCompletedNCT00317720Phase 1/2Results posted
• Phase I/II Study of Chemoprevention With EGFR and COX-2 InhibitorCompletedNCT00314262Phase 1/2Results posted
• ChemoRT With Adjuvant Chemo in Pancreatic Cancer (TARCEVA)CompletedNCT00313560Phase 2Results posted
• ZACTIMA (an Anti-EGFR / Anti-VEGF Agent) Combined With Docetaxel Compared to Docetaxel in Non-small Cell Lung CancerCompletedNCT00312377Phase 3Results posted
• Sirolimus Before Surgery in Treating Patients With Advanced Localized Prostate CancerCompletedNCT00311623Phase 1/2Results posted
• Study Comparing Effect On Carotid Atherosclerosis Following Conversion From Tacrolimus To Sirolimus Post-Transplant In Kidney Transplant PatientsTerminatedNCT00311311Phase 3Results posted
• Cediranib Maleate in Treating Patients With Malignant Mesothelioma That Cannot Be Removed By SurgeryCompletedNCT00309946Phase 2Results posted
• An Open Label Study of Oral Enzastaurin in Participants With CancerCompletedNCT00309140Phase 2Results posted
• First Line Chemotherapy Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00308750Phase 2Results posted
• Bevacizumab, Erlotinib and 5-Fluorouracil With External Beam Radiation Therapy in Locally Advanced Rectal CancerCompletedNCT00307736Phase 1/2Results posted
• Effect of Food Upon Pharmacokinetics of Single Oral Dose of Cediranib (AZD2171, Recentin™)CompletedNCT00306891Phase 2Results posted
• Study of Dasatinib in Children and Adolescents With Relapsed or Refractory LeukemiaCompletedNCT00306202Phase 1Results posted
• Infliximab, Sirolimus and Daclizumab to Treat Age-Related Macular DegenerationCompletedNCT00304954Phase 2Results posted
• Study of RADPLAT and Tarceva in Locally Advanced Head and Neck Squamous Cell Carcinoma (SCCA)CompletedNCT00304278Phase 2Results posted
• Sorafenib in Treating Patients With Relapsed Chronic Lymphocytic LeukemiaTerminatedNCT00303966Phase 2Results posted
• AZD2171 in Treating Patients With Refractory Metastatic Kidney CancerTerminatedNCT00303862Phase 2Results posted
• Oral Tarceva Study for Recurrent/Residual Glioblastoma Multiforme and Anaplastic AstrocytomaCompletedNCT00301418Phase 1/2Results posted
• A Randomized Controlled Trial Comparing Safety and Efficacy of Carboplatin and Paclitaxel Plus or Minus Sorafenib (BAY 43-9006) in Chemonaive Patients With Stage IIIB-IV Non-Small Cell Lung Cancer (NSCLC)TerminatedNCT00300885Phase 3Results posted
• Study Evaluating HKI-272 (Neratinib) In Subjects With Advanced Breast CancerCompletedNCT00300781Phase 2Results posted
• Efficacy and Safety of Everolimus in Recipients of Heart Transplants to Prevent Acute and Chronic RejectionCompletedNCT00300274Phase 3Results posted
• Study of SU11248 in Men With Advanced Prostate CancerCompletedNCT00299741Phase 2Results posted
• Pazopanib In Patients With Relapsed Or Refractory Soft Tissue SarcomaCompletedNCT00297258Phase 2Results posted
• Erlotinib (Tarceva) as a Single Agent or Intercalated With Combination Chemotherapy in Patients With EGFR Positive NSCLCCompletedNCT00294762Phase 2Results posted
• Study Of SU011248 In Combination With Docetaxel In Patients With Metastatic Breast CancerCompletedNCT00291577Phase 1Results posted
• Efficacy and Safety of Imatinib Mesylate Plus Hydroxyurea (HU) in Patients With Recurrent Glioblastoma Multiforme (GBM)TerminatedNCT00290771Phase 2Results posted
• Phase II Study of ZD6474 in Advanced NSCLCTerminatedNCT00290537Phase 2Results posted
• CCI-779 in Treating Patients With Recurrent or Refractory B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic LeukemiaCompletedNCT00290472Phase 2Results posted
• Erlotinib, Paclitaxel, and Carboplatin in Treating Patients With Stage III, Stage IV, or Recurrent Non-Small Cell Lung CancerCompletedNCT00287989Phase 2Results posted
• Bevacizumab and Erlotinib in Inoperable and Metastatic Hepatocellular CarcinomaCompletedNCT00287222Phase 2Results posted
• Pilot Study of Rapamycin as Treatment for Autosomal Dominant Polycystic Kidney Disease (ADPKD)CompletedNCT00286156Phase 1/2Results posted
• Ph II Gemcitabine, Erlotinib, and Gemcitabine With Erlotinib/Elderly Patients W/ IIIB/IV NSCLCCompletedNCT00283244Phase 2Results posted
• Tacrolimus and Sirolimus as Prophylaxis After Allogenic Non-myeloablative Peripheral Blood Stem Cell TransplantationCompletedNCT00282282Phase 2Results posted
• Study Of AG-013736 In Patients With Refractory Metastatic Renal Cell CancerCompletedNCT00282048Phase 2Results posted
• Sorafenib With Either Temsirolimus or Tipifarnib in Treating Patients With Stage IV Malignant Melanoma That Cannot Be Removed By SurgeryCompletedNCT00281957Phase 2Results posted
• Study In Women And Men With Metastatic Breast Cancer That Have Overexpression Of ErbB2CompletedNCT00281658Phase 3Results posted
• A Phase II, Open-Label Study Evaluating the Effect Of GW786034 In Subjects With Ovarian CancerCompletedNCT00281632Phase 2Results posted
• Second Line Erlotinib (Tarceva) Plus Digoxin in Non-Small Cell Lung CancerTerminatedNCT00281021Phase 2Results posted
• An Open Label Phase I Dose Escalation Study of E7080 Administered to Patients With Solid TumorsCompletedNCT00280397Phase 1Results posted
• Second Line ColoRectal Cancer Therapy in Combination With Combination of FOL- Folinic Acid(Leucovorin), F - Fluorouracil and OX - Oxaliplatin (FOLFOX)CompletedNCT00278889Phase 2Results posted
• Adjuvant Imatinib in High-risk Gastrointestinal Stromal Tumor (GIST) With C-kit MutationCompletedNCT00278876Phase 2Results posted
• Cediranib Maleate in Treating Patients With Persistent, Recurrent, or Refractory Advanced Ovarian Epithelial, Peritoneal Cavity, or Fallopian Tube CancerCompletedNCT00278343Phase 2Results posted
• Erlotinib, Paclitaxel, and Carboplatin Combined With Radiation Therapy for Stage III Non-Small Cell Lung CancerCompletedNCT00278148Phase 1/2Results posted
• Individualized Drug Treatment for Treating Patients With Pancreatic CancerTerminatedNCT00276744Phase 2Results posted
• AZD2171 in Treating Patients With Recurrent Ovarian, Peritoneal, or Fallopian Tube CancerCompletedNCT00275028Phase 2Results posted
• ErbB2 Over-expressing Metastatic Breast Cancer Study Using Paclitaxel, Trastuzumab, and LapatinibTerminatedNCT00272987Phase 3Results posted
• Single Agent Erlotinib in Chemotherapy-naive Androgen Independent Prostate CancerCompletedNCT00272038Phase 2Results posted
• Gefitinib in Treating Patients With Recurrent or Metastatic Esophageal or Gastroesophageal Junction CancerCompletedNCT00268346Phase 2Results posted
• Synthetic Vaccine in Patients With Chronic Myeloid Leukemia and Minimal Residual DiseaseCompletedNCT00267085Phase 2Results posted
• Phase 2 Study of Gemcitabine or Gemcitabine + Enzastaurin in Participants With Advanced or Metastatic Pancreatic CancerCompletedNCT00267020Phase 2Results posted
• Study Evaluating the Safety Of HKI-272 (Neratinib) In Subjects With Advanced Non-Small Cell Lung CancerCompletedNCT00266877Phase 2Results posted
• Treatment for Completers of the Study B7A-MC-MBCMCompletedNCT00266695Phase 3Results posted
• Sorafenib in Treating Patients With Malignant Gastrointestinal Stromal Tumor That Progressed During or After Previous Treatment With Imatinib Mesylate and Sunitinib MalateActive, not recruitingNCT00265798Phase 2Results posted
• A Study In Patients With Non-Small Cell Lung Cancer Testing If Erlotinib Plus SU011248 (Sunitinib) Is Better Than Erlotinib AloneCompletedNCT00265317Phase 2Results posted
• Phase II Iressa & Carbo/Gem in NSCLCCompletedNCT00264498Phase 2Results posted
• Study to Investigate the Management of Hypertension and Efficacy of AZD2171 in Patients With Advanced Solid TumoursCompletedNCT00264004Phase 2Results posted
• Lapatinib for Brain Metastases In ErbB2-Positive Breast CancerCompletedNCT00263588Phase 2Results posted
• Extension Study Of Stage 1 Subjects Of Study A3921009 For The Prevention Of Acute Rejection In Kidney Transplant PatientCompletedNCT00263328Phase 2Results posted
• Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive LeukemiasCompletedNCT00261846Phase 2Results posted
• A Study Comparing Bevacizumab Therapy With or Without Erlotinib for First-Line Treatment of Non-Small Cell Lung Cancer (ATLAS)CompletedNCT00257608Phase 3Results posted
• Dasatinib as Therapy for Myeloproliferative Disorders (MPDs)CompletedNCT00255346Phase 2Results posted
• Study of SU011248 in Patients With Advanced Kidney CancerCompletedNCT00254540Phase 2Results posted
• Dasatinib in Treating Patients With Early Chronic Phase Chronic Myelogenous LeukemiaCompletedNCT00254423Phase 2Results posted
• Sorafenib, Docetaxel, and Cisplatin in Treating Patients With Metastatic or Advanced Gastric or Gastroesophageal Junction CancerCompletedNCT00253370Phase 2Results posted
• A Phase I/II Clinical Trial of Vorinostat in Combination With Erlotinib for Patients With Relapsed/Refractory Non-Small-Cell Lung Cancer (0683-025)TerminatedNCT00251589Phase 1/2Results posted
• A Study of Imatinib and Docetaxel in Prostate CancerCompletedNCT00251225Phase 2Results posted
• Efficacy and Safety Study of Everolimus Plus Reduced Cyclosporine Versus Mycophenolic Acid Plus Cyclosporine in Kidney Transplant RecipientsCompletedNCT00251004Phase 3Results posted

← Protein Kinase Inhibitors overview